| Literature DB >> 35252189 |
Xiuna Ji1, Mingyue Zheng2, Tingjun Fan1, Bin Xu1.
Abstract
[This corrects the article DOI: 10.3389/fcell.2021.675998.].Entities:
Keywords: in vitro expansion; limbal stem cells; regenerative medicine; self-renewal; small-molecule compounds
Year: 2022 PMID: 35252189 PMCID: PMC8894700 DOI: 10.3389/fcell.2022.822728
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
FIGURE 1Small-molecular combination as a novel strategy to optimize limbal stem cell (LSC) expansion in culture. GSK3β inhibitors [lithium chloride (LiCl), CHIR-99021], DKK inhibitor (IIIC3), and Wnt mimic (MFH-ND) activate the canonical Wnt pathway to improve LSC expansion. Growth factor (pigment epithelial-derived factor), cytokine (leukemia inhibitory factor), ROCK inhibitor (Y-27632), and BMP signaling inhibitor (LDN-193189) also promote LSC self-renewal through multiple signaling pathways. TGF/β signaling inhibitor (SB431542) and Notch signaling inhibitor (DAPT) prevent epithelial–mesenchymal transition of LSC by inhibiting the corresponding pathways. Histone deacetylase inhibitor (VPA), miRNA agomir/antagomir and nicotinamide adenine dinucleotide (NAD+) precursor [nicotinamide (NAM)] might enhance the efficiency of LSC expansion through the regulation at epigenetic, post-transcriptional, and metabolic levels. ECM, extracellular matrix; EMT, epithelial-mesenchymal transition; miRNA, microRNA.